About Us 

Dedicated to our mission to normalize & professionalize cannabis. 

Cresco Labs is one of the largest publicly traded, vertically integrated, multistate cannabis companies in the U.S. We produce the industrys #1 portfolio of cannabis brands and operate dispensaries under our Sunnyside brand nationally that focus on delivering consumer education, trust and convenience. 

Best-in-Class Cultivation & Manufacturing 

We’re involved at every point in the seed-to-sale process. Our cultivation and manufacturing facilities are powered by world-class agronomists, extraction and R&D experts, and state-of-the-art agricultural equipmentall of which drive our commitment to quality, purity and consistency. We package, ship and distribute our products to cannabis retailers nationwide, including our Sunnyside stores.


Cresco Labs has one of the biggest U.S. footprints that’s growing, with:

  • 8
    Operational States
  • 13
    Production Facilities
  • 71

Cresco branding.

Building National Brands

Rooted in the fundamentals of CPG brand building, we are creating a differentiated portfolio of top cannabis brands that is aligned to distinct audiences, need states and occasions. This approach allows us to best meet people’s needs of today, while also meeting their future needs.

Meet Our Brands 

Wholesale Distribution at Scale

Our branded cannabis products are sold in thousands of dispensaries across the country. We prioritize wholesale to reach as many patients and customers as possible, accessing the scaled benefits of a national footprint.

Partner With Us 

National Retail Footprint

Our Sunnyside dispensaries give us the ability to not only sell our own products, but also focus on educating and building trust within their surrounding communities. Our stores also serve as a critical platform for innovation and powerful consumer insights as we shape the future of cannabis.

See Our Retail Locations 

Social Equity & Education Development

We created the SEED™ initiative (Social Equity & Educational Development) to address the absence of people, businesses and communities disproportionally impacted by the War on Drugs in the cannabis industry. Annually, we’re committed to investing both our time and resources to remedy this inherent inequality through the development of tangible pathways into cannabis.

Learn More